Author

Kevin Clark

Primary ORCID profile (0000-0001-6660-0736 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Kevin ClarkiD1 paper · University of Oxford

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adrien Le Thomas· 1 shared Alvin Gogineni· 1 shared Amy Heidersbach· 1 shared Avi AshkenaziiD· 1 shared Benjamin Haley· 1 shared Daniel W Sherbenou· 1 shared David A Lawrence· 1 shared David Kan· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrien Le Thomas

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 14, 2018

Disruption of IRE1α through its Kinase Domain Attenuates Multiple Myeloma

Jonathan M Harnoss, Adrien Le Thomas, Scot A Marsters…·Avi Ashkenazi

This study shows that disrupting IRE1α's kinase domain reduces multiple myeloma tumor growth and enhances treatment efficacy, suggesting it as a therapeutic target.

DOI 10.1101/495242

humanbulk RNA-seq